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Abstract
Background: Inadequate epidemiologic investigations of the paranasal sinuses malignancies prompted this retro-
spective study with special emphasis on a major group of 111 tumors. 
Material and Methods: Clinical records of 111 patients with histologically confirmed malignant tumors of the 
paranasal sinuses were investigated retrospectively from April 2000 to January 2012. Collection of data included 
demographic information, clinical manifestations, treatment plans, and histopathology of the tumor. 
Results: There were 69 (62.16%) male and 42 (37.83%) female patients (male-to-female ratio of 1.6:1), with a me-
dian age of 49±12.2 years (range 21 to 88 years). A high level of occurrence was noticed in the fifth (26.3%) decade 
of life. The most frequent histological types were squamous cell carcinoma (43.5%) and adenoid cystic carcinoma 
(19%). Among clinical manifestations, nasal obstruction was the most frequent followed by diplopia, and facial 
swelling. Fifty three patients (47.74%) were treated with combined approach of surgery and radiation therapy. 
Conclusions: Paranasal sinuses malignancies are rare conditions with nonspecific symptoms which make early di-
agnosis of the lesions more challenging. The optimal therapeutic protocol for patients suffering from these tumors 
is still a somewhat controversial entity and requires further studies. 
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Introduction
Malignant tumors of the paranasal sinuses are rare but 
serious complications in adults (1). There are different 
factors making diagnosis of these tumors a major chal-
lenge including different histological variations, limited 
anatomic access, and nonspecific clinical manifesta-
tions (2,3).
Air-filled structure of sinuses makes these tumors lo-
cally aggressive. Malignancies of the paranasal sinuses 
are usually presented by extension to the adjacent criti-
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cal organs, which impairs the survival of the patients 
(4). Patients may present with nonspecific symptoms 
such as sinusitis, bleeding of the nose or more advanced 
symptoms when the lesion reaches the skull base or the 
orbit (5). Invasion of these tumors to skull base, optic 
nerve and brain stem makes treatment and rehabilita-
tion of patients more complicated (6).
The therapeutic approach for malignancies of the para-
nasal sinuses is multidisciplinary and consists of sur-
gical and radiological interventions. Due to the rarity 
and diversity of these tumors and insufficient number of 
clinical studies, there is no consensus about therapeutic 
approach for the treatment of tumors of the paranasal 
sinuses (3).
Optimal imaging is needed for determining the origin 
and distribution pattern of the tumor (3,7). Surgical 
treatment protocols have evolved from invasive cranio-
facial resection surgery to more conservative endo-
scopic sinus surgery, in order to lower morbidity rate 
and improve treatment outcome (8,9). Several radio-
therapy techniques have been used in combination with 
surgical procedures to treat patients. Radiotherapy and 
chemotherapy are considered as an alternate treatment 
modalities for the patients who are not indicated for the 
surgical procedure (4).
Inadequate epidemiologic investigations of the parana-
sal sinus malignancies prompted this retrospective study 
with special emphasis on the major group of 111 tumors.
Material and Methods
One hundred and eleven patients diagnosed with malig-
nant tumors of the paranasal sinuses that were treated 
and followed up at an oncology institute between April 
2000 and January 2012 were selected for the present 
study. 
The Ethics Committee of the Medical school approved 
the study protocol. The diagnosis of the paranasal si-
nuses malignancies was histologically confirmed in all 
patients. Exclusion criteria were presence of benign con-
dition, secondary involvement of the paranasal sinuses 
by tumors of distant area and nasopharyngeal lesions. 
Tumor origin and distribution pattern were recognized 
by clinical and radiographic examinations. Records of 
the applied therapeutic modalities were made at oncolo-
gy center. We used the institution surgical and discharge 
registries to evaluate the cases and extract information 
about the variables of interest including diagnosis, his-
tological results, treatment approaches and recurrences. 
The data were analyzed using SPSS 15 software (SPSS, 
version 15, Chicago, U.S). 
Results
There were 69 (62.16%) male and 42 (37.83%) female 
patients (male-to-female ratio of 1.6:1), with a median 
age of 49±12.2 years (range 21 to 88 years). 
The most frequent reported symptoms at the time of 
diagnosis were nasal obstruction, diplopia, facial swell-
ing, epistaxis, proptosis, headache, mass in the nose, 
and auditory disturbance (Table 1). 
Symptoms Frequency Percentage
Nasal obstruction            32 28,8
Diplopia 17 18.8
Facial swelling                           15 16.6
Epistaxis 14 15.5
Proptosis 11 12.2
Headache 9 9.99
Mass in the nose                        10 11.1
Auditory disturbance   3 3.3
Table 1. The most frequent clinical manifestations at presentation.
A high level of occurrence was noticed in the fifth 
(26.3%), sixth (22.7%) and seventh (18%) decades of 
life, in descending order. Tumor histological diagnosis 
revealed that squamous cell carcinoma (SCC) was the 
most frequent malignant tumor (n = 48) followed by ad-
enoid cystic carcinoma (n = 21), adenocarcinoma (n = 
18), sarcoma (n = 10), malignant melanoma (n = 5), ma-
lignant lymphoma (n = 4), and other types of carcinoma 
(n=5) (Fig. 1). 
Aggressive local extension and destruction of adjacent 
structures were observed in most patients. At the time 
of referral, 62 (55.85%) cases presented with orbit in-
volvement. Principle clinical manifestation and oph-
thalmic symptom in different histological subtypes are 
presented in table 2. Distant metastasis was noticed in 
30 (27%) patients at the time of diagnosis of the para-
nasal lesion.
The anatomic location and extent of tumors varied con-
siderably. Tumors of the paranasal sinuses originated 
from the maxillary sinus in 60 patients, ethmoid sinus 
in 39 patients, sphenoid sinus in 11 patients, and frontal 
sinus in 1 patient. In 25% of cases, the lesion involved 
more than one sinus (Table 3).
None of the patients received palliative treatment. In 
the present study, 53 patients were treated with com-
bined approach of surgery and radiation therapy, and 
10 with surgery alone. Nineteen patients were managed 
with chemoradiation therapy, and 11 with radiotherapy 
alone. A combination of surgery and chemotherapy was 
performed in 18 patients.
Endoscopic sinus surgery was the surgical approach for 
treatment of the lesions in 17 cases, whereas the remain-
ing 94 patients were treated with conventional resec-
tion. 
Recurrences were noticed in 61 (55%) patients as local; 
in 14 (13%) patients as local and distant metastases; in 
6 (6%) patients as local and regional recurrences; in 2 
(2%) patients as local, regional, and distant metastasis; 
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in 14 (13%) patients as distant metastasis alone; and 
twelve (11%) patients as regional recurrences alone.
Discussion
Cancer of the paranasal sinuses are rare, yet challeng-
ing, condition with an unknown etiology (1). Epidemio-
logic investigations provide further information on the 
prevalence and symptoms associated with these condi-
tions, which lead to early diagnosis or referral of the 
patient for the treatment. To the best of our knowledge, 
this group of 111 patients with malignancies of the para-
nasal sinuses, treated within 12-year period, represents 
the largest reported series in an Iranian population.
In the current study, median age of patients was 49±12.2 
with male to female ratio 1.6:1. As we found in our 
study, the predominance of men was obvious in previ-
ous works (10,11). The majority of neoplasms occurred 
in the fifth decade of life which are in support with find-
ings in previous studies (2,3).
According to the literature, carcinomas constitute more 
Histological Clinical manifestation Ophthalmic symptom
Squamous cell carcinoma Nasal obstruction Diplopia
Adenoid cystic carcinoma Swelling of the cheek Proptosis
Adenocarcinoma Nasal obstruction Diplopia
Sarcoma Nasal obstruction Proptosis
Malignant melanoma Epistaxis Proptosis
Malignant lymphoma Epistaxis Diplopia
Involved sinuses
Frequency
Number Percentage
Maxillary + ethmoid + sphenoid 1 0.9
Ethmoid + frontal 1 0.9
Ethmoid + sphenoid 5 4.5
Maxillary + sphenoid 1 0.9
Ethmoid + maxillary 20 18.01
Fig. 1. Histological types of tumors.
Table 2. Principle clinical manifestation and ophthalmic symptom in different histological sub-
types.  
Table 3. In advanced cases the lesion involves more than one sinus.
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than 65% of malignant neoplasms of the paranasal si-
nuses (12,13). In concordance with other reports, the 
most prevalent malignant tumors in this study were 
squamous cell carcinoma, adenoid cystic carcinoma, 
and adenocarcinoma (1,12)- However; Zbaren et al. (14) 
reported epidermoid carcinomas (56%) and adenocar-
cinomas (14%) as the most common neoplasms of 216 
cases. A systematic review by Dulguerov et al. (15) 
evaluated sinonasal tumors over the period of 38 years 
and found SCC as the most common tumor, which is in 
support of our results. 
Our results are in good agreement with the previous 
studies where the most frequent primary site of tumors 
was maxillary sinus (87%) followed by ethmoid sinus 
(56%) (12,13). Malignant tumors of the frontal sinus are 
very rare and mainly documented as case reports in lit-
erature (16). In our study, frontal sinus malignancy was 
found only in one case.
In the current study, most common symptoms were na-
sal obstruction, diplopia, and facial swelling. This was 
in contrast to the study of Fasunla et al. (17) who noticed 
epistaxis and swelling of the face as the first and fourth 
most common clinical symptoms. The discrepancy be-
tween our results and previous studies may be due to the 
number of patients evaluated in different studies, ignoring 
nonspecific symptoms and late diagnosis of the lesions.  
There is a gap between the onset of symptoms and final 
diagnosis of the disease in most cases due to nonspecif-
ic manifestations of the paranasal malignancies, which 
misleads patients to receive treatment in an appropriate 
time (18,19).
Epistaxis and diplopia more than any other symptoms 
may provoke patients for further medical consultation 
due to the fear of bleeding and visual impairment (19). 
In the present study, diplopia was the most frequent 
ophthalmic symptom in patients with SCC, adenocar-
cinoma, and malignant lymphoma. Epistaxis was the 
chief complaint in 4 out of 5 patients with malignant 
melanoma. In our study, three patients (3.3 %) suffered 
from auditory disturbance, which was rarely reported 
as clinical symptom in previous works (6,10).
Paranasal sinuses malignancies vary in behavior ac-
cording to anatomical location and histology. Local 
recurrence was the dominant treatment failure in our 
patients. In addition, 20 (18%) patients were recorded 
with regional recurrences and 30 (27%) patients had a 
distant metastasis, which are in agreement with the pre-
vious studies (1,10).
The optimal therapeutic protocol for patients suffering 
from cancers of the paranasal sinuses is still a somewhat 
controversial entity (20,21). Since most patients are diag-
nosed at advanced stages, multidisciplinary approach is 
preferred to treat the disease. Because of the critical posi-
tion of the sinuses adjacent to brain and orbit and their 
bony structure, definitive radiotherapy has not been con-
sidered as the only therapeutic approach (1,20). On the 
other hand, craniofacial resection of malignant tumors 
has high morbidity and involves further treatments to re-
construct the surgical defect. Many clinicians consider 
combination of surgery and radiation therapy as a treat-
ment modality for treating aggressive lesions (10,22). 
Majority of patients in this case series were treated with 
surgery combined with radiation therapy. 
Endoscopic or craniofacial resection are the main surgi-
cal methods applied for optimal treatment of patients 
(1,23). A systematic review of the literature by Higgins 
et al. (24) on the results of craniofacial versus endo-
scopic resection of sinonasal malignancies revealed that 
endoscopic management of sinonasal cancers appears 
to be a promising approach in treatment of low-staged 
esthesioneuroblastomas and adenocarcinomas. In the 
present study, 85% of patients were treated with cranio-
facial resection.
In order to decrease local recurrence rate of aggressive 
tumors, craniofacial resection with modern radiation 
therapy techniques were suggested by some studies 
(1). It is also noteworthy that concomitant chemoradia-
tion therapy is recommended to enhance therapeutic 
outcome in patients with aggressive local craniofacial 
malignant tumors (25). Further randomized controlled 
clinical trials with an adequate sample size are needed 
to standardize the treatment approach for the treatment 
of this condition.
In conclusion, sinonasal malignancies are rare group 
of cancers with squamous cell carcinoma and adenoid 
cystic carcinoma as the most frequent histological 
types. Local recurrence was the main common cause 
of failure followed by distant metastasis and regional 
relapse of the lesions. The optimal therapeutic protocol 
for patients suffering from these tumors is still a some-
what controversial entity. However; combined approach 
including surgery and radiation therapy of patients is 
recommended. Further investigations are required for 
more precise therapeutic protocol.
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